Clinical trials

  • BEVACIZUMAB for Advanced ovarian cancer | Primary peritoneal cancer | Fallopian tube cancer
  • 16-base single stranded RNA targeting miR-23b linked to oleic acid for Myotonic dystrophy type 1
  • sacituzumab tirumotecan for Endometrial cancer
  • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST TFR1 CONJUGATED TO DOUBLE STRANDED SIRNA OLIGONUCLEOTIDE AGAINST DMPK VIA A NON-CLEAVABLE LINKER for Myotonic dystrophy type 1
  • KETAMINE for Traumatic brain injury
  • OBINUTUZUMAB for Systemic lupus erythematosus
  • Durvalumab for Extensive stage small cell lung cancer
  • SURVODUTIDE for Obesity | Non-alcoholic steatohepatitis (NASH)
  • Vedolizumab for Chronic pouchitis | Pouchitis
  • Mupirocin for Impetigo
  • Bevacizumab for Pancreatic well-differentiated neuroendocrine tumor
  • CIPROFLOXACIN for Bronchiectasis